Citations

Mayo Clinic

Showing 10 of 108599 citations.

Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus
Bhat, Shubha , Lyu, Ruishen, Agarwal, Mitali, Becker, Michelle , Bloomfeld, Richard S. , Bruining, David H. , Cohen, Benjamin L, Ivanov, Marina, Leighton, Jonathan A. , Stewart, Alyssa P, Trocke, Lindsay, Tse, Stacy , Vaughn, Byron P. , Regueiro, Miguel, Sokn, Erick, Rieder, Florian , Cohen, Benjamin L, Stewart, Alyssa P., Ungaro, Ryan C. , Regueiro, Miguel

Inflammatory Bowel Diseases | August 31, 2023 | Volume: 30 | Issue: 6 | Pages: 950-959

10.1093/ibd/izad143 | PMID 37650888 Get It

Abstract Background Given the complexity of inflammatory bowel disease (IBD) care, utilization of multidisciplinary teams is recommended to optimize outcomes. There is a growing recognition that clinical pharmacists should be an integral part of this care model. We sought to define the roles of IBD clinical pharmacists in the United States. Methods A national multidisciplinary expert panel of 12 gastroenterologists and clinical pharmacists practicing in IBD clinics was assembled. We used the RAND/University of California, Los Angeles appropriateness method, with a total of 281 statements generated based on a systematic literature review and expert opinion. Each statement was anonymously rated as appropriate, uncertain, or inappropriate in 2 rounds of voting. Results The number of publications evaluating the clinical pharmacists’ roles in IBD is limited, primarily focusing on thiopurine initiation and monitoring, medication adherence, and switching to biosimilars. Medication education; medication initiation and monitoring; therapeutic drug monitoring; biosimilar management; health maintenance review; and transitions of care were deemed by the panel to be appropriate roles for IBD clinical pharmacists. In considering real-world settings, IBD clinical pharmacists should practice clinically under a predefined scope and primarily focus on complex treatments (eg, immunomodulators, biologics, and small molecules). Clinical pharmacists should also be included in practice settings with IBD specialized physicians. Additionally, clinical pharmacists caring for patients with IBD should be residency trained and board certified. Conclusions This consensus defines IBD clinical pharmacists’ roles and provides a framework for embedded clinical pharmacists in IBD care.
Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex across the lifespan
Stevens, Maria , Dykhoff, Hayley J. , Kronzer, Vanessa L. , Myasoedova, Elena , Duarte‐García, Alí , Crowson, Cynthia S. , Stevens, Maria A, Duarte-García, Alí , Crowson, CS , Kronzer, Vanessa L , Myasoedova, Elena , Davis, John M.

Rheumatology | August 31, 2023 | Volume: 63 | Issue: 6 | Pages: 1639-1648

10.1093/rheumatology/kead454 | PMID 37651451 Get It

Abstract Objectives Multimorbidity is burdensome for people with RA. We investigated differences in multimorbidity and comorbidities by sex and age in the RA population. Methods This cross-sectional analysis used national administrative claims (OptumLabs® Data Warehouse) from people with RA and non-RA comparators (matched on age, sex, race, census region, index year and length of baseline insurance coverage) from 2010–2019. RA was determined using a validated algorithm. Multimorbidity was defined as ≥2 (MM2+) or ≥5 (MM5+) comorbidities from a validated set of 44 chronic conditions. We used logistic regression to assess associations between characteristics and multimorbidity. Results The sample included 154 391 RA patients and 154 391 non-RA comparators. For people aged 18–50 years, RA women (vs RA men) had 7.5 and 4.4 (vs 3.2 and 0.9 in non-RA women vs non-RA men) percentage point increases for MM2+ and MM5+, respectively. For people aged 51+ years, RA women (vs RA men) had 2.1 and 2.5 (vs 1.2 and 0.3 in non-RA women vs non-RA men) percentage point increases for MM2+ and MM5+, respectively. Interactions revealed that differences in multimorbidity between women and men were exacerbated by RA (vs non-RA) (P < 0.05), with more pronounced effects in people aged 18–50. Men had more cardiovascular-related conditions, whereas RA women had more psychological, neurological and general musculoskeletal conditions. Other comorbidities varied by sex and age. Conclusion Multimorbidity disproportionately impacts women with RA. Research, clinical and policy agendas for rheumatic diseases should acknowledge and support the variation in care needs by sex and gender across the lifespan.
Amyloid-related Imaging Abnormalities in Alzheimer Disease Treated with Anti–Amyloid-β Therapy
Agarwal, Amit , Brahmbhatt, Pavan , Desai, Amit , Bathla, Girish , Brahmbhatt, Pavan , Desai, Amit , Vibhute, Prasanna , Bathla, Girish , Agarwal, Amit Kumar , Gupta, Vivek , Joseph‐Mathurin, Nelly

RadioGraphics | August 31, 2023 | Volume: 43 | Issue: 9 | Pages: No page available

10.1148/rg.230009 | PMID 37651273 Get It

Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance)
Brown, Justin C. , Shi, Qian , Couture, Félix , Kuebler, Philip , Kumar, Pankaj , Tan, Benjamin , Krishnamurthi, Smitha , Goldberg, Richard M. , Blanke, Charles D. , Shields, Anthony F. , Meyerhardt, Jeffrey A. , Brown, Justin C. , Kumar, Pankaj , O'Reilly, Eileen M , Brown, Justin C , Meyerhardt, Jeffrey A , Shi, Qian , Brown, Justin C. , Ma, Chao , Zemla, Tyler , Chang, Victor T. , Venook, Alan P. , O’Reilly, Eileen M.

Cancer | August 31, 2023 | Volume: 129 | Issue: 23 | Pages: 3724-3734

10.1002/cncr.35007 | PMID 37651160 Get It

AbstractBackgroundOne in three patients with stage III colon cancer will experience tumor recurrence. It is uncertain whether physical activity during and after postoperative chemotherapy for stage III colon cancer improves overall survival after tumor recurrence.MethodsA prospective cohort study nested within a randomized multicenter trial of patients initially diagnosed with stage III colon cancer who experienced tumor recurrence (N = 399) was conducted. Postoperative physical activity before tumor recurrence was measured. Physical activity energy expenditure was quantified via metabolic equivalent task hours per week (MET‐h/week). The primary end point was overall survival after tumor recurrence. Multivariable flexible parametric survival models estimated relative and absolute effects with two‐sided hypothesis tests.ResultsCompared with patients expending <3.0 MET‐h/week of physical activity (comparable to <1.0 h/week of brisk walking), patients with ≥18.0 MET‐h/week of physical activity (comparable to 6 h/week of brisk walking) had a 33% relative improvement in overall survival time after tumor recurrence (hazard ratio, 0.67; 95% CI, 0.42–0.96). The overall survival rate at 3 years after tumor recurrence was 61.3% (95% CI, 51.8%–69.2%) with <3.0 MET‐h/week of physical activity and 72.2% (95% CI, 63.1%–79.6%) with ≥18 MET‐h/week of physical activity (risk difference, 10.9 percentage points; 95% CI, 1.2–20.8 percentage points).ConclusionsHigher postoperative physical activity is associated with improved overall survival after tumor recurrence in patients initially diagnosed with stage III colon cancer. These data may be relevant to patients who, despite optimal postoperative medical therapy, have a high risk of tumor recurrence.
Three-Dimensional Transesophageal Echocardiography in Percutaneous Catheter-Based Cardiac Interventions
Farina, Juan M. , Barry, Timothy , Arsanjani, Reza , Naqvi, Tasneem Z. , Naqvi, Tasneem Z , Arsanjani, Reza , Farina, Juan M

Journal of Clinical Medicine | August 31, 2023 | Volume: 12 | Issue: 17 | Pages: 5664

10.3390/jcm12175664 | PMID 37685731 Get It

Cardiac structural and valve interventions have remained surgical procedures for several decades. The ability to directly visualize the region of interest during surgery made imaging of these structures pre- and postsurgery a secondary tool to compliment surgical visualization. The last two decades, however, have seen rapid advances in catheter-based percutaneous structural heart interventions (SHIs). Due to the “blind” nature of these interventions, imaging plays a crucial role in the success of these procedures. Fluoroscopy is used universally in all percutaneous cardiac SHIs and helps primarily in the visualization of catheters and devices. However, success of these procedures requires visualization of intracardiac soft tissue structures. Due to its portable nature and rapid ability to show cardiac structures online, transesophageal echocardiography (TEE) has become an integral tool for guidance for all percutaneous SHI. Transcatheter aortic valve replacement—one of the earliest catheter-based procedures—while initially dependent on TEE, has largely been replaced by preprocedural cardiac CT for accurate assessment of valve sizing. Developments in echocardiography now allow live three-dimensional (3D) visualization of cardiac structures mimicking surgical anatomy during TEE. Besides showing actual 3D intracardiac structures, 3D-TEE allows visualization of the interaction of intracardiac catheters and devices with soft tissue cardiac structures, thereby becoming a “second pair of eyes” for the operator. Real-time 3D-TEE now plays an important role complementing multiplane two dimensional and biplane TEE during such interventions. In this review, we discuss the incremental role of 3D-TEE during various SHIs performed today.
Augmented Reality and Ultrasound-Guided Vascular Access
Al‐Abcha, Abdullah , Alkhouli, Mohamad , Bell, Malcolm R. , Yalamuri, Suraj , Lerman, Amir , Gulati, Rajiv , Simard, Trevor , Prasad, Abhiram , Bell, Malcolm R , Lerman, Amir , Gulati, Rajiv , Simard, Trevor , Alkhouli, Mohamad , Al-Abcha, Abdulah , Prasad, Abhiram

Circulation: Cardiovascular Interventions | August 31, 2023 | Volume: 16 | Issue: 9 | Pages: No page available

10.1161/circinterventions.123.013360 | PMID 37650286 Get It

Cerebral palsy pain instruments: Recommended tools for clinical research studies by the National Institute of Neurological Disorders and Stroke Cerebral Palsy Common Data Elements project
Schiariti, Verónica , Shierk, Angela , Stashinko, Elaine, Sukal‐Moulton, Theresa , Feldman, Robin , Aman, Clara, Mendoza‐Puccini, Carolina , Brandenburg, Joline E. , Feldman, Robin S , Mendoza-Puccini, Carolina

Developmental Medicine & Child Neurology | August 31, 2023 | Volume: 66 | Issue: 5 | Pages: 610-622

10.1111/dmcn.15743 | PMID 37650571 Get It

AbstractAimThis study describes the process of updating the cerebral palsy (CP) common data elements (CDEs), specifically identifying tools that capture the impact of chronic pain on children's functioning.MethodThrough a partnership between the American Academy for Cerebral Palsy and Developmental Medicine and the National Institute of Neurological Disorders and Stroke (NINDS), the CP CDEs were developed as data standards for clinical research in neuroscience. Chronic pain was underrepresented in the NINDS CP CDEs version 1.0. A multi‐step methodology was applied by an interdisciplinary professional team. Following an adapted CP chronic pain tools' rating system, and a review of psychometric properties, clinical utility, and compliance with inclusion/exclusion criteria, a set of recommended pain tools was posted online for external public comment in May 2022.ResultsFifteen chronic pain tools met inclusion criteria, representing constructs across all components of the International Classification of Functioning, Disability and Health.InterpretationThis paper describes the first condition‐specific pain CDEs for a pediatric population. The proposed set of chronic pain tools complement and enhance the applicability of the existing pediatric CP CDEs. The novel CP CDE pain tools harmonize the assessment of chronic pain, addressing not only intensity of chronic pain, but also the functional impact of experiencing it in everyday activities.
Psilocybin history, action and reaction: A narrative clinical review
Sharma, Pravesh , Nguyen, Quang Anh , Matthews, Sadie J., Mathews, Douglas B, Patten, Christi A. , Sharma, Pravesh , Carpenter, Erin, Mathews, Doug B, Hammond, Christopher J.

Journal of Psychopharmacology | August 31, 2023 | Volume: 37 | Issue: 9 | Pages: 849-865

10.1177/02698811231190858 | PMID 37650489 Get It

Hallucinogenic mushrooms have been used in religious and cultural ceremonies for centuries. Of late, psilocybin, the psychoactive compound in hallucinogenic mushrooms, has received increased public interest as a novel drug for treating mood and substance use disorders (SUDs). In addition, in recent years, some states in the United States have legalized psilocybin for medical and recreational use. Given this, clinicians need to understand the potential benefits and risks related to using psilocybin for therapeutic purposes so that they can accurately advise patients. This expert narrative review summarizes the scientific basis and clinical evidence on the safety and efficacy of psilocybin-assisted therapy for treating psychiatric disorders and SUDs. The results of this review are structured as a more extensive discussion about psilocybin’s history, putative mechanisms of action, and recent legislative changes to its legal status. There is modest evidence of psilocybin-assisted therapy for treating depression and anxiety disorders. In addition, early data suggest that psilocybin-assisted therapy may effectively reduce harmful drinking in patients with alcohol use disorders. The evidence further suggests psilocybin, when administered under supervision (psilocybin-assisted therapy), the side effects experienced are mild and transient. The occurrence of severe adverse events following psilocybin administration is uncommon. Still, a recent clinical trial found that individuals in the psilocybin arm had increased suicidal ideations and non-suicidal self-injurious behaviors. Given this, further investigation into the safety and efficacy of psilocybin-assisted therapy is warranted to determine which patient subgroups are most likely to benefit and which are most likely to experience adverse outcomes related to its use.
What students say to be ready for acute care: Implications for preceptors
Oldenburg, Hannah , Hake, Melissa P. , Rindflesch, Aaron , Hake, Melissa , Oldenburg, Hannah , Rindflesch, Aaron B

The Clinical Teacher | August 31, 2023 | Volume: 21 | Issue: 1 | Pages: No page available

10.1111/tct.13638 | PMID 37650458 Get It

Abstract Background Student readiness for clinical education experiences is an important variable for clinical preceptors. Readiness has been reported from the viewpoints of clinicians, academic faculty, clinical preceptors, employers and novice graduate physical therapists. Perspectives from physical and occupational therapy students could better prepare preceptors in the acute care setting. Approach Thematic analysis was conducted following the approach described by Braun and Clarke. The purpose of this study was to describe physical and occupational therapy student perceptions of readiness for full‐time acute care clinical education experiences. Twenty‐one physical and occupational therapy students in process of completing full‐time clinical education experiences at a large academic medical centre were qualitatively interviewed in small groups. A two‐stage iterative process of thematic inquiry was used to induce themes about student readiness for full‐time acute care clinical experiences. Transcription, coding and thematic analysis were completed. Students also completed a one‐time questionnaire with demographic and learner characteristic scales. Findings Participants were on average 26.4 years old, predominantly female and White, and had completed one full‐time clinical education experience prior to participation. Four major thematic categories of student readiness for acute care clinical experiences emerged: (1) mindset and willingness; (2) knowledge and experience; (3) communication and collaboration; and (4) planning and prioritising. Implications Students report their readiness is facilitated by preceptors who can model flexibility, foster communication that promotes clinical reasoning, implement an orientation to the acute care culture and learning resources and scaffold roles and responsibilities to aid professional authority.